psilocin

Metabolite details

Identifier

SPCIYGNTAMCTRO-UHFFFAOYSA-N

InChI Key

SPCIYGNTAMCTRO-UHFFFAOYSA-N

IUPAC name

3-[2-(dimethylamino)ethyl]-1H-indol-4-ol

Preferred name

psilocin

INN name

—

Synonym

N,N-dimethyl-4-hydroxytryptamine

ChEBI

CHEBI:8613

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Metabolomics Investigation of Dietary Effects on Flesh Quality in Grass Carp (Ctenopharyngodon idellus)
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_Endometrial_Cancer
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Female_Artificial_Feed_vs_Female_Grass_Feed
• Control_vs_BP3_Low_Concentration